Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Angiogenesis
Published in: Angiogenesis 1/2008

01-03-2008 | Original Paper

Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies

Authors: Richard C. A. Sainson, Adrian L. Harris

Published in: Angiogenesis | Issue 1/2008

Login to get access

Abstract

The notch-signalling pathway regulates cell fate and differentiation through cell–cell communication. In recent years, several in vitro and in vivo studies have demonstrated that notch-signalling functions as a negative feedback mechanism downstream of the VEGF-signalling pathway that acts to finely shape the vascular network. Notch activation by the Jagged-1 and Delta-like 4 ligands regulates different steps of blood vessel development ranging from proliferation and survival of endothelial cells, to vessel branching and arterial–venous differentiation. In addition, heterotypic notch signalling from endothelial cells to pericytes is critical for vessel stabilization and maturation. Interestingly, several studies have demonstrated that blocking the notch pathway can delay tumour growth. Unexpectedly however, tumour growth inhibition by Notch was caused by an increased number of non-functional vessels, which resulted in poor tumour perfusion. This approach of modulating notch signalling, combined with the extended knowledge acquired on the basic vascular role of notch signalling, will aid the development of treatments targetting human pathologies such as tissue ischaemia and solid tumour formation.
Literature
1.
2.
Schmidt A, Brixius K, Bloch W (2007) Endothelial precursor cell migration during vasculogenesis. Circ Res 101(2):125–136PubMedCrossRef
3.
Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97(6):512–523PubMedCrossRef
4.
Bray SJ (2006) Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7(9):678–689PubMedCrossRef
5.
Iso T, Kedes L, Hamamori Y (2003) HES and HERP families: multiple effectors of the notch signaling pathway. J Cell Physiol 194(3):237–255PubMedCrossRef
6.
Chitnis A (2006) Why is delta endocytosis required for effective activation of notch? Dev Dyn 235(4):886–894PubMedCrossRef
7.
Le Borgne R, Bardin A, Schweisguth F (2005) The roles of receptor and ligand endocytosis in regulating notch signaling. Development 132(8):1751–1762PubMedCrossRef
8.
Le Borgne R, Schweisguth F (2003) Notch signaling: endocytosis makes delta signal better. Curr Biol 13(7):R273–R275PubMedCrossRef
9.
Wilkin MB, Baron M (2005) Endocytic regulation of notch activation and down-regulation (review). Mol Membr Biol 22(4):279–289PubMedCrossRef
10.
Six E, Ndiaye D, Laabi Y, Brou C, Gupta-Rossi N, Israel A et al (2003) The notch ligand delta1 is sequentially cleaved by an ADAM protease and {gamma}-secretase. Proc Natl Acad Sci U S A
11.
Ikeuchi T, Sisodia SS (2003) The notch ligands, delta1 and jagged2, are substrates for presenilin-dependent “gamma-secretase” cleavage. J Biol Chem 278(10):7751–7754PubMedCrossRef
12.
LaVoie MJ, Selkoe DJ (2003) The notch ligands, jagged and delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments. J Biol Chem 278(36):34427–34437PubMedCrossRef
13.
Martinez Arias A, Zecchini V, Brennan K (2002) CSL-independent notch signalling: a checkpoint in cell fate decisions during development? Curr Opin Genet Dev 12(5):524–533PubMedCrossRef
14.
Morel V, Schweisguth F (2000) Repression by suppressor of hairless and activation by notch are required to define a single row of single-minded expressing cells in the Drosophila embryo. Genes Dev 14(3):377–388PubMed
15.
Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J et al (2005) Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9(5):617–628PubMedCrossRef
16.
Ramain P, Khechumian K, Seugnet L, Arbogast N, Ackermann C, Heitzler P (2001) Novel notch alleles reveal a deltex-dependent pathway repressing neural fate. Curr Biol 11(22):1729–1738PubMedCrossRef
17.
Ross DA, Kadesch T (2004) Consequences of notch-mediated induction of jagged1. Exp Cell Res 296(2):173–182PubMedCrossRef
18.
Ordentlich P, Lin A, Shen CP, Blaumueller C, Matsuno K, Artavanis-Tsakonas S et al (1998) Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol 18(4):2230–2239PubMed
19.
Hodkinson PS, Elliott PA, Lad Y, McHugh BJ, MacKinnon AC, Haslett C et al (2007) Mammalian NOTCH-1 activates beta1 integrins via the small GTPase R-Ras. J Biol Chem 282(39):28991–29001PubMedCrossRef
20.
Okajima T, Irvine KD (2002) Regulation of notch signaling by O-linked fucose. Cell 111(6):893–904PubMedCrossRef
21.
Stanley P (2007) Regulation of notch signaling by glycosylation. Curr Opin Struct Biol 17(5):530–535PubMedCrossRef
22.
Shi S, Stanley P (2003) Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. Proc Natl Acad Sci U S A 100(9):5234–5239PubMedCrossRef
23.
Haltiwanger RS, Stanley P (2002) Modulation of receptor signaling by glycosylation: fringe is an O-fucose-beta1,3-N-acetylglucosaminyltransferase. Biochim Biophys Acta 1573(3):328–335PubMed
24.
Yang LT, Nichols JT, Yao C, Manilay JO, Robey EA, Weinmaster G (2005) Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1. Mol Biol Cell 16(2):927–942PubMedCrossRef
25.
Harrington LS, Sainson RC, Williams CK, Taylor JM, Shi W, Li JL et al (2007) Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvasc Res
26.
Llimargas M (1999) The Notch pathway helps to pattern the tips of the Drosophila tracheal branches by selecting cell fates. Development 126(11):2355–2364PubMed
27.
Wan S, Cato AM, Skaer H (2000) Multiple signalling pathways establish cell fate and cell number in Drosophila malpighian tubules. Dev Biol 217(1):153–165PubMedCrossRef
28.
Sainson RC, Aoto J, Nakatsu MN, Holderfield M, Conn E, Koller E et al (2005) Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. Faseb J 19(8):1027–1029PubMed
29.
Hofmann JJ, Luisa Iruela-Arispe M (2006) Notch expression patterns in the retina: an eye on receptor-ligand distribution during angiogenesis. Gene Expr Patterns
30.
Karsan A (2005) The role of notch in modeling and maintaining the vasculature. Can J Physiol Pharmacol 83(1):14–23PubMedCrossRef
31.
Lovschall H, Mitsiadis TA, Poulsen K, Jensen KH, Kjeldsen AL (2007) Coexpression of Notch3 and Rgs5 in the pericyte-vascular smooth muscle cell axis in response to pulp injury. Int J Dev Biol 51(8):715–721PubMedCrossRef
32.
Mailhos C, Modlich U, Lewis J, Harris A, Bicknell R, Ish-Horowicz D (2001) Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 69(2–3):135–144PubMedCrossRef
33.
Shutter JR, Scully S, Fan W, Richards WG, Kitajewski J, Deblandre GA et al (2000) Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev 14(11):1313–1318PubMed
34.
Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J (1996) Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122(7):2251–2259PubMed
35.
Yoneya T, Tahara T, Nagao K, Yamada Y, Yamamoto T, Osawa M et al (2001) Molecular cloning of delta-4, a new mouse and human Notch ligand. J Biochem (Tokyo) 129(1):27–34
36.
Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP et al (2000) Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14(11):1343–1352PubMed
37.
Limbourg FP, Takeshita K, Radtke F, Bronson RT, Chin MT, Liao JK (2005) Essential role of endothelial Notch1 in angiogenesis. Circulation 111(14):1826–1832PubMedCrossRef
38.
Uyttendaele H, Ho J, Rossant J, Kitajewski J (2001) Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci U S A 98(10):5643–5648PubMedCrossRef
39.
Hrabe de Angelis M, McIntyre J, II, Gossler A (1997) Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 386(6626):717–721
40.
Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C et al (1999) Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8(5):723–730PubMedCrossRef
41.
Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E et al (2004) Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 18(20):2474–2478PubMedCrossRef
42.
Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, Valenzuela DM et al (2004) Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci U S A 101(45):15949–15954PubMedCrossRef
43.
Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T (2004) Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev
44.
Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M et al (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380(6573):435–439PubMedCrossRef
45.
Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O’Shea KS et al (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380(6573):439–442PubMedCrossRef
46.
Oka C, Nakano T, Wakeham A, de la Pompa JL, Mori C, Sakai T et al (1995) Disruption of the mouse RBP-J kappa gene results in early embryonic death. Development 121(10):3291–3301PubMed
47.
Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M (2004) The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18(8):901–911PubMedCrossRef
48.
Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling—in control of vascular function. Nat Rev Mol Cell Biol 7(5):359–371PubMedCrossRef
49.
Liu ZJ, Shirakawa T, Li Y, Soma A, Oka M, Dotto GP et al (2003) Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 23(1):14–25PubMedCrossRef
50.
Patel NS, Li JL, Generali D, Poulsom R, Cranston DW, Harris AL (2005) Up-regulation of Delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 65(19):8690–8697PubMedCrossRef
51.
Williams CK, Li JL, Murga M, Harris AL, Tosato G (2006) Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 107(3):931–939PubMedCrossRef
52.
Holderfield MT, Henderson Anderson AM, Kokubo H, Chin MT, Johnson RL, Hughes CC (2006) HESR1/CHF2 suppresses VEGFR2 transcription independent of binding to E-boxes. Biochem Biophys Res Commun
53.
Taylor KL, Henderson AM, Hughes CC (2002) Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. Microvasc Res 64(3):372–383PubMedCrossRef
54.
Liu ZJ, Xiao M, Balint K, Soma A, Pinnix CC, Capobianco AJ et al (2006) Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. Faseb J 20(7):1009–1011PubMedCrossRef
55.
Noseda M, McLean G, Niessen K, Chang L, Pollet I, Montpetit R et al (2004) Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res
56.
Noseda M, Niessen K, McLean G, Chang L, Karsan A (2005) Notch-dependent cell cycle arrest is associated with downregulation of minichromosome maintenance proteins. Circ Res 97(2):102–104PubMedCrossRef
57.
Shawber CJ, Funahashi Y, Francisco E, Vorontchikhina M, Kitamura Y, Stowell SA et al (2007) Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J Clin Invest 117(11):3369–3382PubMedCrossRef
58.
MacKenzie F, Duriez P, Wong F, Noseda M, Karsan A (2003) Notch4 inhibits endothelial apoptosis via RBP-Jkappa-dependent and -independent pathways. J Biol Chem
59.
Gerhardt H, Betsholtz C (2005) How do endothelial cells orientate? Exs (94):3–15
60.
Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A et al (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6):1163–1177PubMedCrossRef
61.
Hellstrom M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P et al (2007) Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature
62.
Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD et al (2007) Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A 104(9):3219–3224PubMedCrossRef
63.
Suchting S, Freitas C, le Noble F, Benedito R, Breant C, Duarte A et al (2007) The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci U S A
64.
Leslie JD, Ariza-McNaughton L, Bermange AL, McAdow R, Johnson SL, Lewis J (2007) Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 134(5):839–844PubMedCrossRef
65.
Siekmann AF, Lawson ND (2007) Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445(7129):781–784PubMedCrossRef
66.
Roca C, Adams RH (2007) Regulation of vascular morphogenesis by Notch signaling. Genes Dev 21(20):2511–2524PubMedCrossRef
67.
Savagner P (2001) Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23(10):912–923PubMedCrossRef
68.
Endo Y, Osumi N, Wakamatsu Y (2002) Bimodal functions of Notch-mediated signaling are involved in neural crest formation during avian ectoderm development. Development 129(4):863–873PubMed
69.
Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I et al (2007) Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through slug-induced repression of E-cadherin. J Exp Med 204(12):2935–2948PubMedCrossRef
70.
Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. Embo J 23(5):1155–1165PubMedCrossRef
71.
Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA et al (2001) Notch signaling is required for arterial–venous differentiation during embryonic vascular development. Development 128(19):3675–3683PubMed
72.
Zhong TP, Childs S, Leu JP, Fishman MC (2001) Gridlock signalling pathway fashions the first embryonic artery. Nature 414(6860):216–220PubMedCrossRef
73.
Diez H, Fischer A, Winkler A, Hu CJ, Hatzopoulos AK, Breier G et al (2007) Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp Cell Res 313(1):1–9PubMedCrossRef
74.
Iso T, Maeno T, Oike Y, Yamazaki M, Doi H, Arai M et al (2006) Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells. Biochem Biophys Res Commun
75.
You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, Tsai SY (2005) Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435(7038):98–104PubMedCrossRef
76.
Carlson TR, Yan Y, Wu X, Lam MT, Tang GL, Beverly LJ et al (2005) Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci U S A 102(28):9884–9889PubMedCrossRef
77.
Limbourg A, Ploom M, Elligsen D, Sorensen I, Ziegelhoeffer T, Gossler A et al (2007) Notch ligand Delta-like 1 is essential for postnatal arteriogenesis. Circ Res 100(3):363–371PubMedCrossRef
78.
Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, Mukai Y et al (2007) Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res 100(1):70–78PubMedCrossRef
79.
80.
von Tell D, Armulik A, Betsholtz C (2006) Pericytes and vascular stability. Exp Cell Res 312(5):623–629CrossRef
81.
Peault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, Partridge T et al (2007) Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 15(5):867–877PubMedCrossRef
82.
Wang T, Baron M, Trump D (2007) An overview of Notch3 function in vascular smooth muscle cells. Prog Biophys Mol Biol
83.
Louvi A, Arboleda-Velasquez JF, Artavanis-Tsakonas S (2006) CADASIL: a critical look at a Notch disease. Dev Neurosci 28(1–2):5–12PubMedCrossRef
84.
Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, Krebs LT et al (2004) Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 18(22):2730–2735PubMedCrossRef
85.
Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M et al (2007) Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 67(23):11244–11253PubMedCrossRef
86.
Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R et al (2007) Inhibition of Dll4 mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood
87.
Hellstrom M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H et al (2001) Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153(3):543–553PubMedCrossRef
88.
Foo SS, Turner CJ, Adams S, Compagni A, Aubyn D, Kogata N et al (2006) Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124(1):161–173PubMedCrossRef
89.
Kamath BM, Spinner NB, Emerick KM, Chudley AE, Booth C, Piccoli DA et al (2004) Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 109(11):1354–1358PubMedCrossRef
90.
Donovan J, Kordylewska A, Jan YN, Utset MF (2002) Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol 12(18):1605–1610PubMedCrossRef
91.
Borzychowski AM, Sargent IL, Redman CW (2006) Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 11(5):309–316PubMedCrossRef
92.
Cobellis L, Mastrogiacomo A, Federico E, Schettino MT, De Falco M, Manente L et al (2007) Distribution of Notch protein members in normal and preeclampsia-complicated placentas. Cell Tissue Res 330(3):527–534PubMedCrossRef
93.
Radtke F, Raj K (2003) The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3(10):756–767PubMedCrossRef
94.
Patel NS, Dobbie MS, Rochester M, Steers G, Poulsom R, Le Monnier K et al (2006) Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer. Clin Cancer Res 12(16):4836–4844PubMedCrossRef
95.
Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW et al (2006) Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444(7122):1032–1037PubMedCrossRef
96.
Ozawa MG, Yao VJ, Chanthery YH, Troncoso P, Uemura A, Varner AS et al (2005) Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma. Cancer 104(10):2104–2115PubMedCrossRef
97.
Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160(3):985–1000PubMed
98.
Zeng Q, Li S, Chepeha DB, Giordano TJ, Li J, Zhang H et al (2005) Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8(1):13–23PubMedCrossRef
99.
Shih Ie M, Wang TL (2007) Notch signaling, gamma-secretase inhibitors, and cancer therapy. Cancer Res 67(5):1879–1882PubMedCrossRef
100.
Hallahan AR, Pritchard JI, Hansen S, Benson M, Stoeck J, Hatton BA et al (2004) The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res 64(21):7794–7800PubMedCrossRef
101.
O’Neil J, Calvo J, McKenna K, Krishnamoorthy V, Aster JC, Bassing CH et al (2006) Activating Notch1 mutations in mouse models of T-ALL. Blood 107(2):781–785PubMedCrossRef
102.
van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H et al (2005) Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435(7044):959–963PubMedCrossRef
103.
Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y et al (2006) Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444(7122):1083–1087PubMedCrossRef
104.
Sainson RC, Harris AL (2007) Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis? Trends Mol Med 13(9):389–395PubMedCrossRef
105.
Lu C, Kamat AA, Lin YG, Merritt WM, Landen CN, Kim TJ et al (2007) Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma. Clin Cancer Res 13(14):4209–4217PubMedCrossRef
106.
Jain RK, Duda DG, Clark JW, Loeffler JS (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 3(1):24–40PubMedCrossRef
107.
Fung E, Tang SM, Canner JP, Morishige K, Arboleda-Velasquez JF, Cardoso AA et al (2007) Delta-like 4 induces notch signaling in macrophages: implications for inflammation. Circulation 115(23):2948–2956PubMedCrossRef
108.
Knowles HJ, Harris AL (2007) Macrophages and the hypoxic tumour microenvironment. Front Biosci 12:4298–4314PubMedCrossRef
Metadata
Title
Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies
Authors
Richard C. A. Sainson
Adrian L. Harris
Publication date
01-03-2008
Publisher
Springer Netherlands
Published in
Angiogenesis / Issue 1/2008
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-008-9098-0

Other articles of this Issue 1/2008

Angiogenesis 1/2008 Go to the issue

Original Paper

Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis

Original paper

Endoglin in angiogenesis and vascular diseases

Original Paper

Hedgehog signalling in vascular development

Original paper

Sprouty proteins, masterminds of receptor tyrosine kinase signaling

Original Paper

Wnt/Frizzled signaling in angiogenesis

Original Paper

NF-κB: a new player in angiostatic therapy
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits